|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Loss on disposal of property, plant and equipment | |||||
| Gain on debt restructuring | |||||
| Interest expense | |||||
| Depreciation of property, plant and equipment | |||||
| Amortization of land use rights and intangible assets | |||||
| Noncash lease expenses | |||||
| Share-based compensation | |||||
| Changes in fair value of warrant liability | |||||
| Changes in fair value of Bridge Notes | |||||
| Changes in fair value of warrant liability and convertible loan | |||||
| Allowance of credit losses | |||||
| Write-down for obsolete inventories | |||||
| Impairment loss of long-lived assets | |||||
| Product warranty | |||||
| Deferred tax benefit | |||||
| Changes in operating assets and liabilities: | |||||
| Notes receivable | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Prepaid expenses and other current assets | |||||
| Amounts due from/to related parties | |||||
| Operating lease right-of-use assets | |||||
| Other non-current assets | |||||
| Notes payable | |||||
| Accounts payable | |||||
| Advance from customers | |||||
| Accrued expenses and other liabilities | |||||
| Operating lease liabilities | |||||
| Other non-current liabilities | |||||
| Net cash generated in operating activities | |||||
| Cash flows from investing activities | |||||
| Purchases of property, plant and equipment | |||||
| Proceeds on disposal of property, plant and equipment | |||||
| Purchase of short-term investments | |||||
| Proceeds from maturity of short-term investments | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities | |||||
| Proceeds from bank borrowings | |||||
| Repayment of bonds payable | |||||
| Repayment of bank borrowings | |||||
| Convertible loan | |||||
| Repayment of related party loans | |||||
| Cash received from the trust account upon Merger, net of transaction costs (Note 3) | |||||
| Cash received from Private Investment in Public Equity (“PIPE”) investors upon Merger (Note 3) | |||||
| Payment to exited noncontrolling interests (Note 19) | |||||
| Issuance of Bridge Notes (Note 14) | |||||
| Payment for debt issuance costs | |||||
| Proceeds from sale of common stocks | |||||
| Payment for equity issuance costs | |||||
| Deferred payment related to purchases of property, plant and equipment | |||||
| Net cash (used in)/ provided by financing activities | |||||
| Effect of exchange rate changes | |||||
| Increase/ (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of the year | |||||
| Cash, cash equivalents and restricted cash at end of the year | |||||
| Supplemental disclosure of cash flow information | |||||
| Interest paid | |||||
| Income tax paid | |||||
| Non-cash investing and financing activities | |||||
| Payable for purchase of property, plant and equipment | |||||
| Notes receivable in exchange for property, plant and equipment | |||||
| Reconciliation to amounts on consolidated balance sheets | |||||
| Cash and cash equivalents | |||||
| Restricted cash | |||||
Loading...